tirezepatide vs semaglutide POTD: Wegovy and Ozempic — Maimonides Emergency Medicine Residency Switching from Semaglutide to Tirzepatide

In cases described in the literature, this remission has been maintained in the long term46

among them, the rounded-down age of the participants was 54 years, where 59% were females and the average body weight was 108.7 kg, and the average BMI was 37.9

Clinical trials have consistently shown that oral semaglutide produces weight-loss results comparable to the injectable version

It contains the same active ingredient as the Wegovy injection and as Rybelsus (the lower-dose oral semaglutide licensed for type 2 diabetes), but at a higher strength approved specifically for weight management

Non-invasive and simple tests, such as the fibrosis index-4 (FIB-4) or the NAFLD fibrosis score (NFS), can be used to evaluate liver fibrosis

With expert dietitian guidance and strategies, the Healthy GLP-1 Journey will help you achieve lasting weight loss